Metabolic Approaches to Cancer: What Integrative Oncology Reveals About the Body’s Internal Environment

Cancer is often viewed as an external enemy, an affliction that strikes without warning and demands an all-out war. But beneath the surface of this harrowing experience lies an invitation - a searing inner process that forces us to confront our deepest fears, our unresolved traumas, and the very fabric of our lives. When we shift our perspective, cancer can become a gateway to transformation, an opportunity to reclaim our health, resilience, and personal agency.

What if the question you have been asking about cancer is the wrong one?

Most people diagnosed with cancer are handed a protocol and told to follow it. The biology of the tumor gets mapped, staged, and targeted. What rarely gets examined is the internal environment that allowed that tumor to take hold in the first place. The terrain. The metabolic dysfunction. The chronic nervous system dysregulation that preceded the diagnosis by years, sometimes decades. If you are someone who suspects there is more to this story than what you have been told, you are right.

I work at the intersection of integrative oncology, functional medicine, and naturopathic medicine because the standard model, as sophisticated as it is, is asking an incomplete set of questions. Treating cancer without addressing the biology that hosts it is like removing mold from a wall without fixing the moisture problem. The conditions remain. And that matters enormously for long-term outcomes.

Cancer Is Predominantly a Metabolic Disease

This is not a fringe position. It is where the science is going. While genetics are part of the picture, inherited mutations account for only 5 to 10 percent of cancer cases (Hanahan and Weinberg, 2011; Anand et al., 2008). The vast majority arise from lifestyle, environmental exposure, and metabolic dysfunction that accumulates over time. This means cancer is not primarily fate. It is biology that has been pushed past a threshold.

Otto Warburg observed in the 1920s that cancer cells preferentially ferment glucose even in the presence of oxygen, a phenomenon now called the Warburg effect (Warburg, 1956). What this tells us is that cancer cells have a metabolic signature, and that signature creates a target. When you shift the body’s internal environment, you change the conditions under which cancer either progresses or is held in check.

In clinical practice, this means I am looking at insulin resistance, mitochondrial function, inflammatory burden, and the metabolic flexibility of the individual in front of me. These are not abstract concepts. They are measurable, modifiable, and profoundly relevant to outcomes.

The Terrain Is Not Separate From the Nervous System

Here is where integrative oncology parts ways with the conventional model in a way that I think is essential to understand. The internal environment is not purely biochemical. It is also neurological.

Chronic stress, unresolved trauma, and sustained sympathetic nervous system activation contribute to the same downstream biology that drives cancer progression: elevated cortisol, suppressed natural killer cell activity, increased inflammatory cytokines, and impaired cellular repair (Glaser and Kiecolt-Glaser, 2005; Sephton and Spiegel, 2003). The polyvagal framework developed by Stephen Porges gives us a way to understand how the autonomic nervous system mediates this connection between psychological experience and physiological state. Vagal tone is not a soft concept. It has direct implications for immune function, inflammation, and the body’s capacity to mount an effective anti-tumor response.

If you have ever wondered why two people with the same diagnosis, the same stage, the same treatment, can have profoundly different outcomes, this is part of the answer. The body you are living in, the nervous system you are operating from, the unprocessed grief or chronic hypervigilance you carry into that treatment room, these are variables. They are not fixed. And they are addressable.

What a Metabolic Approach Actually Looks Like

When I work with someone navigating a cancer diagnosis or focused on prevention and recurrence reduction, the metabolic strategy is specific and grounded in mechanism, not trend.

Reducing glucose availability to cancer cells through therapeutic carbohydrate restriction or a well-formulated ketogenic diet has accumulated meaningful evidence, particularly in glioblastoma, breast, and colorectal cancers (Klement and Kämmerer, 2011; Woolf et al., 2016). This is not a universal prescription. It is a clinical tool that requires individualized assessment of metabolic status, tumor type, and treatment context.

Intermittent fasting and time-restricted eating promote autophagy, the cellular housekeeping process through which damaged organelles and misfolded proteins are cleared. Dysregulated autophagy is implicated in cancer initiation and treatment resistance (Galluzzi et al., 2015). Supporting it through structured fasting protocols can enhance the efficacy of conventional treatment while reducing systemic inflammation.

Mitochondrial function is a central target. Cancer cells carry dysfunctional mitochondria, and supporting mitochondrial integrity through targeted supplementation (coenzyme Q10, alpha-lipoic acid, NAD+ precursors), reducing mitochondrial toxin exposure, and improving cellular oxygenation through movement and breathwork are all part of a coherent metabolic strategy.

None of this replaces conventional oncology where it is indicated. It works alongside it, addressing the terrain that conventional treatment does not reach.

Naturopathic Oncology: The Evidence Behind the Integration

Naturopathic oncology is a licensed specialty. I hold board certification through the American Board of Naturopathic Oncology (FABNO), which requires demonstrated competency in integrating evidence-based natural therapies with conventional cancer treatment. This is not wellness coaching. It is clinical medicine with a broader lens.

The evidence base for specific botanical agents in cancer care has grown considerably. Medicinal mushrooms, including Ganoderma lucidum (reishi) and Trametes versicolor (turkey tail) have demonstrated immunomodulatory effects and, in the case of turkey tail, a well-designed randomized trial showing improved disease-free survival in breast cancer following standard treatment (Standish et al., 2008). Curcumin has been studied extensively for its effects on NF-kB inhibition, a transcription factor central to inflammatory signaling and tumor survival (Gupta et al., 2011). Melatonin, at doses far beyond what most practitioners prescribe, has shown anti-proliferative effects across multiple cancer types (Reiter et al., 2017).

Detoxification support matters not as a vague concept but as a clinical reality. The liver is the primary organ of phase I and phase II detoxification, and its function directly affects the clearance of carcinogens, the metabolism of endogenous hormones (particularly estrogen), and the processing of chemotherapy agents. Supporting hepatic function through dietary intervention, specific nutrients, and reduction of toxic load is a standard component of integrative oncology care, not an optional add-on.

The Emotional Terrain Is Biological

I work within the frameworks of Internal Family Systems and Compassionate Inquiry because I have seen, consistently, that unaddressed psychological material shows up in the body. This is not metaphorical. Adverse childhood experiences are associated with significantly elevated rates of autoimmune disease, cardiovascular disease, and cancer (Felitti et al., 1998). The ACE study is one of the most replicated findings in medicine, and yet it is almost entirely absent from the oncology consultation room.

When I ask someone about their history of chronic stress, their relationship to their own emotions, or the ways in which their body has been carrying what the mind could not process, I am not departing from clinical medicine. I am practicing it more completely.

What aspects of your health history have never been fully explored? What has your body been trying to communicate that you have not yet had the language or the space to hear?

These are not rhetorical questions. They are clinical ones.

Resilience Is a Physiology, Not a Mindset

The word resilience has been overused to the point of losing meaning, but its underlying biology is concrete. Heart rate variability, a measure of autonomic flexibility and vagal tone, is associated with immune competence, cortisol regulation, and the capacity to tolerate physiological stress (Thayer et al., 2012). Resilience is measurable. It is trainable. And it is directly relevant to cancer outcomes.

Practices that increase vagal tone, including slow diaphragmatic breathing, cold exposure, rhythmic movement, social engagement, and structured meditation, are not adjuncts. They are part of the physiological substrate that determines how well your body responds to treatment and maintains health after it.

This is what I mean when I speak about personal agency in the context of cancer. It is not about forced positivity or spiritual bypassing. It is about recognizing that your biology is responsive, that the conditions of your internal environment are modifiable, and that you have more influence over those conditions than anyone may have told you.

Who This Work Is For

If you are someone who has received a cancer diagnosis and feels that there is more to understand than your oncology team has had the time to explore, you are probably right. If you are focused on prevention or reducing recurrence risk and you want a framework that goes beyond generic lifestyle advice, this work is for you. If you are already in treatment and want to optimize your terrain, support your immune function, and address the physiological burden of the treatment itself, integrative oncology has specific, evidence-based tools that can help.

What I offer is not an alternative to conventional medicine. It is the medicine that addresses what conventional oncology does not have time to address: the terrain, the metabolism, the nervous system, the history, and the human being navigating all of it.

The biology of cancer is complex. The body’s capacity for repair and adaptation is equally complex. Understanding both is where meaningful change becomes possible.

References

Anand P, Kunnumakara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharmaceutical Research. 2008;25(9):2097-2116.

Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) study. American Journal of Preventive Medicine. 1998;14(4):245-258.

Galluzzi L, Pietrocola F, Bravo-San Pedro JM, et al. Autophagy in malignant transformation and cancer progression. EMBO Journal. 2015;34(7):856-880.

Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: implications for health. Nature Reviews Immunology. 2005;5(3):243-251.

Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clinical and Experimental Pharmacology and Physiology. 2011;39(3):283-299.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674.

Klement RJ, Kämmerer U. Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutrition and Metabolism. 2011;8:75.

Reiter RJ, Rosales-Corral SA, Tan DX, et al. Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cellular and Molecular Life Sciences. 2017;74(21):3863-3881.

Sephton SE, Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain, Behavior, and Immunity. 2003;17(5):321-328.

Standish LJ, Wenner CA, Sweet ES, et al. Trametes versicolor mushroom immune therapy in breast cancer. Journal of the Society for Integrative Oncology. 2008;6(3):122-128.

Thayer JF, Åhs F, Fredrikson M, Sollers JJ, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neuroscience and Biobehavioral Reviews. 2012;36(2):747-756.

Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309-314.

Woolf EC, Scheck AC. The ketogenic diet for the treatment of malignant glioma. Journal of Lipid Research. 2015;56(1):5-10.